2019
DOI: 10.1080/13696998.2019.1588738
|View full text |Cite
|
Sign up to set email alerts
|

Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review

Abstract: Aims:The overall cost and health-related quality of life (HRQoL) associated with current treatments for chronic kidney disease (CKD)-related anemia are not well characterized. A systematic literature review (SLR) was conducted on the costs and HRQoL associated with current treatments for CKD-related anemia among dialysis-dependent (DD) patients. Materials and methods: The authors searched the Cochrane Library, MEDLINE, EMBASE, NHS EED, and NHS HTA for English-language publications. Original studies published b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
35
0
4

Year Published

2020
2020
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 64 publications
(39 citation statements)
references
References 79 publications
0
35
0
4
Order By: Relevance
“…Anemia is a common complication in patients with chronic kidney disease, especially in those on dialysis. Treatment of renal anemia is associated with improvement in cardiovascular function, and health related quality of life, reducing requirements for blood transfusion and hospitalization [18][19][20]. Erythropoiesis-stimulating agents are one of main treatments for anemia in dialysis [21].…”
Section: Discussionmentioning
confidence: 99%
“…Anemia is a common complication in patients with chronic kidney disease, especially in those on dialysis. Treatment of renal anemia is associated with improvement in cardiovascular function, and health related quality of life, reducing requirements for blood transfusion and hospitalization [18][19][20]. Erythropoiesis-stimulating agents are one of main treatments for anemia in dialysis [21].…”
Section: Discussionmentioning
confidence: 99%
“…World Kidney Day 2021 would like to promote to the policy makers on increasing focus and resources on both drug and nondrug programmes in improving patient wellness. Examples include funding for erythropoiesis‐stimulating agents and antipruritic agents for managing anaemia and itchiness, respectively, just to name a few (Spinowitz et al, 2019; Sukul et al, 2019). Home dialysis therapies have been consistently found to improve patient autonomy and flexibility, quality of life in a cost‐effective manner, enhancing life participation.…”
Section: World Kidney Day 2021 Advocacymentioning
confidence: 99%
“…World Kidney Day 2021 would like to promote to policy makers on increasing focus and resources on both drug and non‐drug programmes in improving patient wellness. Examples include funding for erythropoiesis‐stimulating agents and anti‐pruritic agents for managing anaemia and itchiness, respectively, just to name but a few 15,16 . Home dialysis therapies have been consistently found to improve patient autonomy and flexibility, quality of life in a cost‐effective manner and enhancing life participation.…”
Section: World Kidney Day 2021 Advocacymentioning
confidence: 99%